FindMyKOL
Clinical trialNCT02446405Active, not recruitingPhase 3Interventional

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

SponsorUniversity of SydneyEnrollment1,125Prostatic Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the effectiveness of enzalutamide, versus a conventional non-steroidal anti androgen (NSAA), when combined with a luteinizing hormone releasing hormone analog (LHRHA) or surgical castration, as first line androgen deprivation therapy (ADT) for newly diagnosed metastatic prostate cancer.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

82 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Chris O'Brien Lifehouse

    Camperdown, New South Wales, Australia

  • Coffs Harbour Health Campus

    Coffs Harbour, New South Wales, Australia

  • Concord Cancer Centre - Concord Repatriation General Hospital

    Concord, New South Wales, Australia

  • St Vincent'S Hospital Sydney

    Darlinghurst, New South Wales, Australia

  • Nepean Cancer Care Centre

    Kingswood, New South Wales, Australia

  • St. George Hospital

    Kogarah, New South Wales, Australia

  • Central West Cancer Services

    Orange, New South Wales, Australia

  • Port Macquarie Base Hospital

    Port Macquarie, New South Wales, Australia

  • Prince of Wales Hospital

    Randwick, New South Wales, Australia

  • Genesis Care North Shore

    St Leonards, New South Wales, Australia

  • Tamworth Rural Referral Hospital

    Tamworth, New South Wales, Australia

  • the Tweed Hospital

    Tweed Heads, New South Wales, Australia

  • Riverina Cancer Care Centre

    Wagga Wagga, New South Wales, Australia

  • Sydney Adventist Hospital

    Wahroonga, New South Wales, Australia

  • Wollongong Hospital

    Wollongong, New South Wales, Australia

  • Royal Darwin Hospital

    Tiwi, Northern Territory, Australia

  • Sunshine Coast University Hospital

    Birtinya, Queensland, Australia

  • Townsville Hospital

    Douglas, Queensland, Australia

  • Royal Brisbane and Women'S Hospital

    Herston, Queensland, Australia

  • Gold Coast University Hospital

    Southport, Queensland, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia

  • Adelaide Cancer Centre - Ashford Cancer Care Centre

    Kurralta Park, South Australia, Australia

  • Royal Hobart Hospital

    Hobart, Tasmania, Australia

  • Bendigo Hospital

    Bendigo, Victoria, Australia

  • Monash Cancer Centre Moorabbin

    Bentleigh East, Victoria, Australia

  • Peter Maccallum Cancer Centre - East Melbourne

    East Melbourne, Victoria, Australia

  • St. Vincents Hospital Melbourne

    Fitzroy, Victoria, Australia

  • Peninsula South Eastern Haematology & Oncology Group- Peninsula Oncology Centre

    Frankston, Victoria, Australia

  • University Hospital Geelong

    Geelong, Victoria, Australia

  • Austin Hospital

    Heidelberg, Victoria, Australia

  • Australian Urology Associates

    Malvern, Victoria, Australia

  • Eastern Health Box Hill Hospital

    Melbourne, Victoria, Australia

  • Goulburn Valley Health

    Shepparton, Victoria, Australia

  • Border Medical Oncology

    Wodonga, Victoria, Australia

  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, Australia

  • Fiona Stanley Hospital (formerly Royal Perth Hospital)

    Perth, Western Australia, Australia

Canada
  • Prostate Cancer Institute - Southern Alberta Institute of Urology

    Calgary, Alberta, Canada

  • Cross Cancer Institute

    Edmonton, Alberta, Canada

42 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Enzalutamide →LHRHA or Surgical CastrationNSAA
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2014
Primary completion
31 Dec 2026
Completion
30 Jun 2027
Last update posted
6 Feb 2025
Registered enrollment
1,125
Registry id
NCT02446405

Cross-registrations

ANZCTR (AU/NZ)ACTRN12614000110684

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.